SCHEMBL288520

SCHEMBL288520

CCC(c1ccc(C(N)=O)c(F)c1C(=O)c1c[nH]c2nccnc12)S(=O)(=O)O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 9/20 0.34
CYP2C19 P33261 9/20 0.34
CYP2C9 P11712 9/20 0.34
BRAF P15056 2/20 0.34
BMPR1B O00238 1/20 0.34
PLK4 O00444 1/20 0.34
PIR O00625 1/20 0.34
AURKA O14965 1/20 0.34
DCLK1 O15075 1/20 0.34
EPHB6 O15197 1/20 0.34
RIPK2 O43353 1/20 0.34
STK16 O75716 1/20 0.34
OXSR1 O95747 1/20 0.34
MAP4K4 O95819 1/20 0.34
ABL1 P00519 1/20 0.34
RAF1 P04049 1/20 0.34
LCK P06239 1/20 0.34
FYN P06241 1/20 0.34
FES P07332 1/20 0.34
CSF1R P07333 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL297931 0.87 BRAF (0.43) CYP3A4CYP2C19CYP2C9BRAFBMPR1B
SCHEMBL287953 0.83 CYP2C9 (0.42) CYP3A4CYP2C19CYP2C9BRAFBMPR1B
SCHEMBL994632 0.83 BRAF (0.45) CYP3A4CYP2C19CYP2C9BRAFBMPR1B
SCHEMBL285511 0.81 BRAF (0.44) CYP3A4CYP2C19CYP2C9BRAFBMPR1B
SCHEMBL413438 0.81 BRAF (0.45) CYP3A4CYP2C19CYP2C9BRAFBMPR1B
SCHEMBL995687 0.81 BRAF (0.56) CYP3A4CYP2C19CYP2C9BRAFBMPR1B
SCHEMBL288265 0.81 CYP2C9 (0.53) CYP3A4CYP2C19CYP2C9
SCHEMBL1818826 0.81 CYP2C19 (0.55) CYP3A4CYP2C19CYP2C9
SCHEMBL297872 0.80 CYP2C9 (0.48) CYP3A4CYP2C19CYP2C9BRAFRIPK2
SCHEMBL2353091 0.80 BRAF (0.42) CYP3A4CYP2C19CYP2C9BRAFBMPR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2427433-A1 SOLID FORMS OF SULFONAMIDES AND AMINO ACIDS Plexxikon, Inc. (US) 2012-03-14 EP disclosed
US-8110576-B2 Pyrrolo(2,3-b)pyrazine compounds; Raf kinase inhibitors including A-Raf, B-Raf and/or c-Raf-1 oncogenes; melanoma, colorectal cancer, thyroid cancer, ovarian cancer, cholangiocarcinoma, pain or polycystic kidney disease PLEXXIKON INC. (US) 2012-02-07 US disclosed